Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells
- PMID: 1485890
- DOI: 10.1007/BF00788668
Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells
Abstract
The effects of a c-myc antisense phosphorothioate DNA oligonucleotide were assessed on the proliferation rate of human arterial smooth muscle cells (HSMCs). Compared to a control oligonucleotide the antisense oligonucleotide suppressed the proliferation of HSMCs in a concentration-dependent manner without a major cytotoxic effect. Outgrowth of HSMCs from media explants was significantly inhibited as well. Induction of c-myc expression by serum stimulation of cells was blunted by the antisense oligonucleotide, as shown by immunoblotting. These results demonstrate that c-myc expression is an essential factor for proliferation of HSMCs after growth stimulation, and they show the potential of antisense technology for modulating gene expression of HSMCs in vitro.
Similar articles
-
Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.J Clin Invest. 1994 Feb;93(2):820-8. doi: 10.1172/JCI117036. J Clin Invest. 1994. PMID: 8113414 Free PMC article.
-
The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):4051-5. doi: 10.1073/pnas.92.9.4051. Proc Natl Acad Sci U S A. 1995. PMID: 7732029 Free PMC article.
-
Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.Cancer Res. 1991 Aug 1;51(15):3996-4000. Cancer Res. 1991. PMID: 1855215
-
[Suppression of the exaggerated growth of vascular smooth muscle cells from SHR by antisense oligodeoxynucleotide to TGF beta].Nihon Rinsho. 1993 Jun;51(6):1663-7. Nihon Rinsho. 1993. PMID: 8320846 Review. Japanese.
-
In vivo studies with antisense oligonucleotides.Trends Pharmacol Sci. 1997 Jan;18(1):12-8. doi: 10.1016/s0165-6147(96)01002-4. Trends Pharmacol Sci. 1997. PMID: 9114724 Review. No abstract available.
Cited by
-
Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.J Clin Invest. 1994 Feb;93(2):820-8. doi: 10.1172/JCI117036. J Clin Invest. 1994. PMID: 8113414 Free PMC article.
-
Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest?Biochem J. 1994 Sep 15;302 ( Pt 3)(Pt 3):701-8. doi: 10.1042/bj3020701. Biochem J. 1994. PMID: 7524476 Free PMC article.
-
Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides.J Clin Invest. 1996 Jul 15;98(2):443-50. doi: 10.1172/JCI118810. J Clin Invest. 1996. PMID: 8755655 Free PMC article.
-
Nucleolar stress induces a senescence-like phenotype in smooth muscle cells and promotes development of vascular degeneration.Aging (Albany NY). 2020 Nov 4;12(21):22174-22198. doi: 10.18632/aging.104094. Epub 2020 Nov 4. Aging (Albany NY). 2020. PMID: 33146634 Free PMC article.
-
The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):4051-5. doi: 10.1073/pnas.92.9.4051. Proc Natl Acad Sci U S A. 1995. PMID: 7732029 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources